Related references
Note: Only part of the references are listed.Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality The Women's Health Initiative Randomized Trials
Joann E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Promotion and marketing of bioidentical hormone therapy on the internet: a content analysis of websites
Nese Yuksel et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Fungal Infections Associated with Contaminated Steroid Injections
Carol A. Kauffman et al.
MICROBIOLOGY SPECTRUM (2016)
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
Reduction in Ephedra Poisonings after FDA Ban
Michele Zell-Kanter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ethical problems with bioidentical hormone therapy
M. S. Rosenthal
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments
L Rajkumar et al.
BREAST CANCER RESEARCH (2004)
Estrogen plus progestin and the risk of coronary heart disease
JE Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
